Cardiac crossroads: deciding between mechanical or bioprosthetic heart valve replacement
Authors:
- Tom MaddoxTMTom Maddox
Open Access
- 1 February 2011
- journal article
- review article
- Published by Taylor & Francis in Patient Preference and Adherence
- Vol. 5, 91-99
Abstract
Nearly 15 million people in the United States suffer from either aortic or mitral valvular disease. For patients with severe and symptomatic valvular heart disease, valve replacement surgery improves morbidity and mortality outcomes. In 2009, 90,000 valve replacement surgeries were performed in the United States. This review evaluates the advantages and disadvantages of mechanical and bioprosthetic prosthetic heart valves as well as the factors for consideration in deciding the appropriate valve type for an individual patient. Although many caveats exist, the general recommendation is for patients younger than 60 to 65 years to receive mechanical valves due to the valve's longer durability and for patients older than 60 to 65 years to receive a bioprosthetic valve to avoid complications with anticoagulants. Situations that warrant special consideration include patient co-morbidities, the need for anticoagulation, and the potential for pregnancy. Once these characteristics have been considered, patients' values, anxieties, and expectations for their lifestyle and quality of life should be incorporated into final valve selection. Decision aids can be useful in integrating preferences in the valve decision. Finally, future directions in valve technology, anticoagulation, and medical decision-making are discussed.Keywords
This publication has 42 references indexed in Scilit:
- Choice of Prosthetic Heart Valve in AdultsJACC, 2010
- Hemodynamic Factors Affecting the Fate of Valvular BioprosthesisCirculation, 2010
- Postoperative lipid-lowering therapy and bioprosthesis structural valve deterioration: justification for a randomised trial?European Journal of Cardio-Thoracic Surgery, 2010
- ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart DiseaseCirculation, 2006
- Performance of bioprostheses and mechanical prostheses assessed by composites of valve-related complications to 15 years after aortic valve replacementThe Journal of Thoracic and Cardiovascular Surgery, 2006
- Does the type of biological valve affect patient outcome?Interactive CardioVascular and Thoracic Surgery, 2006
- Comparison of outcomes after aortic valve replacement with a mechanical valve or a bioprosthesis using microsimulationHeart, 2004
- Prevalence and correlates of mitral regurgitation in a population-based sample (the Strong Heart Study)∗∗The views expressed in this study are those of the authors and do not necessarily reflect those of the Indian Health Service.The American Journal of Cardiology, 2001
- Incorporating Risk Attitude into Markov-process Decision Models:Medical Decision Making, 1997
- Fourteen-year experience with homovital homografts for aortic valve replacementThe Journal of Thoracic and Cardiovascular Surgery, 1995